1. AHRO : Austin Health Research Online
  2. Austin Health research
  3. Journal articles
Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/16306
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBeasley, Richard W-
dc.contributor.authorChien, Jimmy-
dc.contributor.authorDouglas, James-
dc.contributor.authorEastlake, Leonie-
dc.contributor.authorFarah, Claude-
dc.contributor.authorKing, Gregory-
dc.contributor.authorMoore, Rosemary P-
dc.contributor.authorPilcher, Janine-
dc.contributor.authorRichards, Michael-
dc.contributor.authorSmith, Sheree-
dc.contributor.authorWalters, Haydn-
dc.date2016-09-01-
dc.date.accessioned2016-09-29T05:39:26Z-
dc.date.available2016-09-29T05:39:26Z-
dc.date.issued2016-09-01-
dc.identifier.citationRespirology 2016; online first: 1 Septemberen_US
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/16306-
dc.description.abstractThis scientific letter considers the rationale for the target oxygen saturation measured by pulse oximetry (SpO2 ) range of 92-96% for oxygen therapy in adult patients without COPD or other conditions associated with chronic respiratory failure, recommended by the Thoracic Society of Australia and New Zealand, in contrast to the 94-98% target range recommended by the British Thoracic Society. We conclude from the available evidence that the SpO2 target of 92-96% may be preferable to 94-98%.en_US
dc.subjectAdulten_US
dc.subjectGuidelineen_US
dc.subjectOxygenen_US
dc.subjectOxygen inhalation therapyen_US
dc.subjectTarget oxygen saturation rangeen_US
dc.titleTarget oxygen saturation range: 92-96% versus 94-98en_US
dc.typeJournal Articleen_US
dc.identifier.journaltitleRespirologyen_US
dc.identifier.affiliationMedical Research Institute of New Zealand, Wellington, New Zealanden_US
dc.identifier.affiliationCapital Coast District Health Board, Wellington, New Zealanden_US
dc.identifier.affiliationLudwig Engel Centre for Respiratory Research, Westmead Hospital and University of Sydney, Sydney, NSW, Australiaen_US
dc.identifier.affiliationDepartment of Respiratory Medicine, The Prince Charles Hospital, Brisbane, Queensland, Australiaen_US
dc.identifier.affiliationConcord Hospital, Macquarie University and University of Sydney, Sydney, NSW, Australiaen_US
dc.identifier.affiliationWoolcock Institute of Medical Research, Royal North Shore Hospital and University of Sydney, Sydney, NSW, Australiaen_US
dc.identifier.affiliationInstitute for Breathing and Sleep, Austin Health, Heidelberg, Victoria, Australiaen_US
dc.identifier.affiliationSchool of Biological Sciences, Victoria University Wellington, Wellington, New Zealanden_US
dc.identifier.affiliationSchool of Nursing and Midwifery, University of Western Sydney, Sydney, NSW, Australiaen_US
dc.identifier.affiliationCRE for Chronic Respiratory Disease, University of Tasmania, Hobart, Tasmania, Australiaen_US
dc.identifier.pubmedurihttps://pubmed.ncbi.nlm.nih.gov/27587269en_US
dc.identifier.doi10.1111/resp.12879en_US
dc.type.contentTexten_US
dc.type.austinJournal Articleen_US
local.name.researcherMoore, Rosemary P
item.openairetypeJournal Article-
item.cerifentitytypePublications-
item.grantfulltextnone-
item.fulltextNo Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
crisitem.author.deptInstitute for Breathing and Sleep-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

44
checked on Nov 27, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.